COVID-19 vaccines: Live updates

Can I still get Covid after the vaccine?

88 / 100

Can I still get Covid after the vaccine?

If someone is unlucky to get Covid after having been vaccinated and you can still, in some cases, get Covid after you get vaccinated, even though your chances seem to be lower, it is likely you will experience a much milder disease

COVID-19 vaccines: Live updates

07/05/2021 14:09 GMT — Can COVID-19 vaccines affect periods?

Some anecdotal reports suggest that, occasionally, menstruating people experience changes to their periods after a COVID-19 vaccine. According to some of these reports, people may experience heavier, more painful, or longer-than-usual periods following a COVID-19 shot.

medical News Today has spoken to Dr. Katharine Lee, a postdoctoral research fellow in the Division of Public Health Sciences at the Washington University School of Medicine in St. Louis, MO, and Dr. Kathryn Clancy, an associate professor in the Department of Anthropology at the University of Illinois at Urbana-Champaign to find out more about how these changes might manifest, who might experience them, and why.

We also spoke to two physicians — Dr. Tara Scott andDr.Kathleen Jordan — and four women who experienced changes to their periods after a COVID-19 vaccine.

“[I]t would have been good to be prepared for [this possibility] ahead of time and for the scientific community to take this impact [of COVID-19 vaccines] seriously, as women do tend to just suffer through it,” one of these women told us.

07/02/2021 13:36 GMT — Longer gap between COVID-19 vaccine doses may increase immune response

A new study provides reassurance that a longer gap between the first and second doses of the Oxford-AstraZeneca vaccine will not compromise a person’s immune response. A gap of up to 45 weeks actually led to a stronger immune response compared with the recommended interval.

07/02/2021 12:29 GMT — J&J vaccine protects against delta variant

In a press release, Johnson & Johnson announced that according to recent data, its single-shot vaccine “generated strong, persistent activity against the rapidly spreading delta variant and other highly prevalent SARS-CoV-2 viral variants.” The company also explains that the protection persisted for the full 8 months that researchers have evaluated to date.

“Today’s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally,” says Dr. Paul Stoffels, vice chairman of the Executive Committee and chief scientific officer at Johnson & Johnson.

“We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the delta variant,” he continues. “This adds to the robust body of clinical data supporting our single-shot vaccine’s ability to protect against multiple variants of concern.”


07/02/2021 09:41 GMT — Moderna, Pfizer vaccines reduce severity and viral load for those who still contract SARS-CoV-2

A recent study investigated how well the Moderna and Pfizer mRNA vaccines prevented and attenuated COVID-19 in real-world conditions. The authors conclude that they were “highly effective” at preventing infection. Also, those who did contract the virus experienced less severe symptoms and a shorter illness.

Back to top button